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Nontypeable Haemophilus influenzae (NTHI) is a Gram-negative bacterial pathogen that causes upper and
lower respiratory infections. Factors required for pulmonary infection by NTHI are not well understood.
Previously, using high-throughput insertion tracking by deep sequencing (HITS), putative lung colonization
factors were identified. Also, previous research indicates that secreted disulfide-dependent factors are impor-
tant for virulence of H. influenzae. In the present study, HITS data were compared with an informatics-based
list of putative substrates of the periplasmic oxidoreductase DsbA to find and characterize secreted virulence
factors. This analysis resulted in identification of the “zinc binding essential for virulence” (zev) locus
consisting of zevA (HI1249) and zevB (HI1248). NTHI mutants of zevA and zevB grew normally in rich medium
but were defective for colonization in a mouse lung model. Mutants also exhibited severe growth defects in
medium containing EDTA and were rescued by supplementation with zinc. Additionally, purified recombinant
ZevA was found to bind to zinc with high affinity. Together, these data demonstrate that zevAB is a novel
virulence factor important for zinc utilization of H. influenzae under conditions where zinc is limiting. Fur-
thermore, evidence presented here suggests that zinc limitation is likely an important mechanism for host
defense against pathogens during lung infection.
Nontypeable Haemophilus influenzae (NTHI) is a Gram-
negative bacterial pathogen uniquely adapted to colonize the
nasopharynx of healthy humans, with a carriage frequency of
approximately 20 to 80% (46). An opportunistic pathogen,
NTHI resides asymptomatically in the upper airways of hu-
mans but can disseminate into privileged anatomical locations,
causing infections such as otitis media, sinusitis, and pneumo-
nia (47). NTHI is also one of the most prevalent microorgan-
isms found in the lungs of patients with exacerbations of
chronic obstructive pulmonary disease (48, 49, 60) and cystic
fibrosis (23, 43, 58). An effective vaccine against NTHI strains
has not yet been discovered, likely due to high variability of
surface antigens between strains (60).
Little is known regarding factors required for survival of H.
influenzae in the lung. To address this, we recently examined a
transposon mutant library of H. influenzae Rd in a mouse lung
infection model using a novel technique termed high-through-
put insertion tracking by deep sequencing (HITS) (22). HITS
analysis revealed a total of 136 genes required for survival in
this site, including previously identified virulence determi-
nants, such as those involved in lipooligosaccharide synthesis
(51), as well as several genes previously unrecognized to play a
role in pathogenesis, some of which are implicated in diverse
processes, including DNA repair, membrane remodeling, and
nutrient acquisition. However, many genes identified by HITS
have unknown functions and have yet to be characterized.
Previously, the periplasmic disulfide bond pathway was in-
vestigated to find virulence determinates of H. influenzae (56).
Disulfide formation is mediated by the periplasmic oxido-
reductase protein DsbA, which directly catalyzes disulfide
bond formation by transferring its disulfide to free thiol groups
of cysteine residues in secreted target proteins (19, 76). This
system is important for providing structural stability and func-
tion to secreted virulence factors in a range of bacterial patho-
gens (30). DsbA was demonstrated to be required for patho-
genesis of H. influenzae in a mouse model of bacteremia (56).
Additionally, the heme-binding lipoprotein HbpA, an impor-
tant factor required for growth of H. influenzae on several
heme sources (26, 44), was found to be a substrate of DsbA
and was required for pathogenesis. However, the defect of an
hbpA mutant was not as severe as that of a dsbA mutant,
suggesting that other, unidentified DsbA-dependent factors
must be required for pathogenesis.
Since a DsbA-dependent protein was found to have a role in
virulence of H. influenzae, we hypothesized that by examining
genes required in the lung, additional DsbA-dependent factors
involved in infection could be found. In this study, potential
DsbA substrates were identified based on predicted extracyto-
plasmic localization and putative disulfide bond formation.
The whole-genome fitness data generated via the HITS pro-
cedure was used to identify candidate DsbA substrates re-
quired for survival of H. influenzae in the lung. This approach
led us to characterize a locus important for zinc utilization,
herein referred to as “zinc binding essential for virulence”
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(zev). This locus contains an operon consisting of two genes,
the potential DsbA substrate zevA and a gene encoding a
putative membrane protein called zevB. In contrast to the
previously characterized ZnuABC zinc transport system, which
is required for optimal growth in rich culture medium in vitro
(39), the zevAB system is specifically required for growth under
severe zinc limitation. The results of this study suggest that the
lung represents a niche that exposes infecting pathogens to
severe zinc limitation and that the zevAB system is required for
zinc homeostasis of H. influenzae during pathogenesis.
MATERIALS AND METHODS
Strains and culture conditions. H. influenzae RdAW (GenBank accession
no. NZ_ACSM00000000), a capsule-deficient serotype d derivative (70), and
pathogenic nontypeable H. influenzae strain NT127 (GenBank accession no.
NZ_ACSL00000000) were grown in brain heart infusion (BHI) broth supple-
mented with 10 g/ml hemin and 10 g/ml NAD (sBHI) or on sBHI agar plates
at 35°C. To generate an anaerobic environment, strains were grown in anaerobic
chambers with BBL GasPak Plus generators (Becton Dickinson and Company,
Sparks, MD). Development of competence for transformation of H. influenzae
was accomplished as previously described (5). For selection of Rd- and NTHI-
derived strains, antibiotics were used at the following concentrations: 8 g/ml
tetracycline (Tc), 20 g/ml kanamycin (Km), and 10 g/ml gentamicin (Gm). For
strain generation, plasmids and PCR products were constructed using standard
molecular biology techniques (4). For complementation of mutants, DNA frag-
ments were amplified by PCR and cloned between adjacent SapI restriction sites
of the chromosomal delivery vector pXT10, linearized, and used to transform H.
influenzae strains as previously described (70).
zevA strain construction. The NTHI zevA mutant strain NT1249G was con-
structed by replacement of the coding sequence of zevA (NT127 locus tag
HIAG_01363) with the Gm resistance cassette aacC1. To do this, a 707-bp PCR
product containing the 5 flanking region of zevA, generated using primers
1249for and 1249B (see Table S1 in the supplemental material), a 762-bp PCR
product containing the coding region for the Gm resistance cassette, generated
with primers 5pGent1 and 3Gent2, and a 1,661-bp PCR product containing the
3 flanking region of zevA, generated with primers 1249A and 1248rev, were
joined by overlap extension PCR, via complementary ends, using primers 1249for
and 1248rev. The resulting 3,086-bp fragment was introduced into competent
cells of strain NTX, a derivative of NT127 in which the xylose locus was modified
for efficient recombination with plasmid pXT10 and its derivatives (28). Gm-
resistant (Gmr) transformants were selected on sBHI containing Gm, creating
strain NTzevAG. NTzevAG was transformed with linearized “empty vector”
pXT10, and Tcr transformants were isolated to create strain NTzevAV. Double
crossovers into the zevA locus were verified using primers 51249test and
31249test, which bind outside the recombination junctions.
To complement the zevA deletion, zevA and upstream promoter elements were
amplified by PCR with primers 51249HA and 31249R, which introduce SapI
restriction sites at the termini of the fragment. The resulting 1,017-bp fragment
was digested with SapI and cloned into SapI-digested vector pXT10, creating
plasmid pX1249J. Plasmid pX1249J was linearized with ApaLI and introduced
into competent cells of strain NT1249G. Tcr recombinants were selected on
sBHI containing Tc, resulting in strain NTzevAX.
zevB strain construction. Deletion of zevB in NTHI was also performed by
replacement of the coding region of zevB (HIAG_01364) with the Gm resistance
gene. To increase the efficiency of mutant selection, the aacC1 promoter was
replaced with the H. influenzae arcA promoter. First, a 1,332-bp fragment con-
taining the 5 flanking region of zevB, amplified by PCR using NT127 genomic
DNA as a template with primers 1249for and 1248JBpArcA, a 762-bp fragment
carrying the arcA promoter fused to the coding region of the Gm resistance gene
from aacC1, amplified from a pXT10 plasmid using primers 5pArcA and 3Gent2,
and a 1,326-bp fragment containing the 3 flanking region of zevB, amplified from
NT127 genomic DNA using primers 1248AHib and 1247RevJB, were joined by
overlap extension PCR using primers 1249for and 1247RevJB. The resulting
3,638-bp fragment was used to transform competent cells of strain NTX. Gmr
transformants were selected on sBHI-Gm plates, resulting in strain NTzevBG.
NTzevBG was then transformed with linearized vector pXT10, and Tcr trans-
formants were isolated to create strain NTzevBV. Double crossovers into the
zevB locus were verified using primers 51249test and 31249test, which bind
outside the recombination junctions.
To complement the zevB mutant, the region consisting of zevA, zevB, and
upstream promoter elements was amplified by PCR with primers 51249HA and
31248R, which introduce SapI restriction sites at the termini of the fragment.
The resulting 1,988-bp fragment was digested with SapI and cloned into SapI-
digested vector pXT10, creating plasmid pX1248J. Plasmid pX1248J was linear-
ized with ApaLI and introduced into competent cells of strain NT1248G. Tcr
recombinants were selected on sBHI containing Tc, resulting in strain NTzevBX.
For performing mixed infections with zevA and zevB mutant strains, a refer-
ence strain featuring a xylose-inducible lacZ gene was generated by transforming
NT127 with ApaLI-digested plasmid pXELacZ2, which contains lacZ in place of
xylA. Tcr recombinants were selected on sBHI containing Tc, resulting in strain
NTlacZ.
znuA and znuBC strain construction. For generating an NTHI znuA
(HIAG_01677) mutant, a 971-bp fragment containing the 5 flanking region of
znuA was amplified from NT127 genomic DNA with primers 5ZnuA1 and
3ZnuA1. A 1,065-bp fragment containing the trc promoter fused to the Km
resistance gene (aphI), amplified from plasmid pENTtrcK (containing the mini-
mariner transposon mmTrcK previously described [22]) with primers IFTrcF and
3kan1, and a 1,065 bp fragment containing the 3 flanking region of znuA,
amplified from NT127 genomic DNA with primers 5ZnuA3 and 3ZnuA3, were
joined using overlap extension PCR by virtue of their complementary ends with
primers 5ZnuA1 and 3ZnuA3. The resulting 3,033-bp fragment was introduced
into competent cells of strains NTV, NTzevAV, and NTzevBV, and Km-resistant
(Kmr) colonies were selected on sBHI-Km, resulting in strains NTznuA,
NTzevAznuA, and NTzevBznuA, respectively. Double crossovers into the znuA
locus were verified using primers 5znuAtest and 3znuAtest, which bind outside
the recombination junctions.
For generating an NTHI znuBC (HIAG_00759 and HIAG_00758) mutant, a
1,592-bp fragment containing the 5 flanking region of the znuBC operon, am-
plified from NT127 genomic DNA with primers 5ZnuB1 and 3ZnuB1, the
1,065-bp fragment described above, containing the trc promoter fused to the Km
resistance gene, and a 1,027 bp fragment containing the 3 flanking region of
znuBC, amplified from NT127 genomic DNA with primers 5ZnuA3 and
3ZnuA3, were joined using overlap extension PCR by virtue of their comple-
mentary ends using primers 5ZnuB1 and 3ZnuB3. The resulting 3,700-bp frag-
ment was introduced into competent cells of strains NTV, NTzevAV, and
NTzevBV, and Kmr colonies were selected on sBHI-Km, resulting in strains
NTznuBC, NTzevAznuBC, and NTzevBznuBC, respectively. Double crossovers
into the znuBC locus were verified using primers 5znuBCtest and 3znuBCtest,
which bind outside the recombination junctions.
zevA reporter strain construction. To generate the reporter strain R5, we
replaced the coding region of zevAB (HI1249 and HI1248) in Rd with a reporter
construct containing the lacZ gene, designed to fuse the zevA promoter to the
translational start of lacZ, and used the tetAR Tc resistance operon as a select-
able marker. To do this, a 683-bp fragment containing the 5 flanking region from
zevA, amplified by PCR from Rd genomic DNA with primers 1249for and
1249BL, a 6,869-bp fragment containing the lacZ gene and tetAR, amplified from
plasmid pXELacZ2 with primers LacFor2 and tetB, and a 689-bp fragment
containing the 3 flanking region of zevB, amplified from Rd genomic DNA with
primers 1248AL and 1248rev, were joined using overlap extension PCR with
primers 1249for and 1248rev. The resulting 8,188-bp fragment was used to
transform Rd competent cells. Tcr transformants were selected on medium
containing Tc, resulting in strain R5.
To complement mutation of zevAB in R5, a 1,988-bp fragment containing the
zevAB coding regions as well as upstream promoter elements was amplified by
PCR from Rd genomic DNA with primers 51249HA and 31248R, which intro-
duce SapI restriction sites at the termini. The resulting fragment was digested
with SapI and cloned into SapI-digested vector pXT10, creating plasmid
pX1248R. Next, a 2,891-bp fragment containing the xylF gene as well as the 5
flanking and coding regions of zevAB, amplified from plasmid pX1248R with
primers pXT10thyAF and 31248gent, the 762-bp Gm resistance cassette frag-
ment described above, and a 1,794-bp fragment containing the xylB gene, am-
plified from pXT10 with primers 5xylBgent and 3revrfad1, were joined using
overlap extension PCR with primers pXT10thyAF and 3revrfad1. The resulting
5,447-bp fragment was used to transform competent cells of strain R5, resulting
in R5X.
fnr mutant construction. For mutation of fnr (HI1425), a 4,230-bp fragment
containing the fnr gene with a magellan1 transposon insertion 170 bp from the
5 end of the FNR translational start was amplified by PCR from previously
described strain Rfnr (28) with primers 5FNRcloning and 3FNRcloning and used
to transform competent R5 cells. Kmr transformants were selected on sBHI-Km,
and the mutation was verified by PCR, resulting in strain R5fnr.
To complement the fnr mutation, a 2,201-bp fragment containing xylF, the fnr
promoter, and fnr (amplified by PCR from strain RfnrC with primers pxt10thyAF
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and 3FNRgent), the 762-bp Gm resistance cassette fragment described above,
and a 1,794-bp fragment containing the xylB gene (amplified from pXT10 with
primers 5xylBgent and 3revrfad1) were joined using overlap extension PCR with
primers pXT10thyAF and 3revrfad1. The resulting 4,733-bp fragment was used
to transform competent cells of strain R5fnr, and the mutation was verified by
PCR, resulting in strain R5fnrX.
His-tagged ZevA construction. To generate the ZevA-His fusion, a 618-bp
fragment containing the zevA gene was amplified from NT127 genomic DNA
template with primers 51249JTOPO and 31249JTOPO. Primer 31249TOPO
adds a tobacco etch virus (TEV) protease cleavage site to the 3 end of the zevA
gene (66). The 618-bp fragment was then TA cloned into the pBAD-TOPO-TA
cloning vector (Invitrogen, Carlsbad, CA), which adds a C-terminal 6His tag
(immediately after the TEV cleavage site), and transformed into One Shot
TOP10 E. coli (Invitrogen, Carlsbad, CA), creating strain ECZevAHIS, which
harbors plasmid pZevAHIS. Plasmid pZevAHIS was verified by sequencing.
Genetic footprinting. H. influenzae Rd genomic DNA from input and output
libraries was used as a template for genetic footprinting analysis as previously
described (1, 61). PCRs were performed using the transposon-specific primer
marout and gene-specific primer 3129rev, which binds 661 bp downstream of the
zevB gene, and visualized on a 0.9% agarose gel stained with ethidium bromide.
Migration distances and gene positions were determined as described previously
(22, 59).
Murine lung infection model. Standing overnight cultures were used to inoc-
ulate 25 ml of sBHI in a 50-ml flask to a final optical density at 600 nm (OD600)
of 0.01. The resulting cultures were incubated with shaking at 250 rpm and 35°C
until mid-log phase. Experimental strains were either mixed with the NTlacZ
reference strain at a 1:1 ratio (mixed infections) or not mixed (single-strain
infections), washed, and diluted in Hanks balanced salt solution (HBSS) to
obtain a final concentration of 5  108 bacteria per ml. Forty microliters of
bacteria (2  107 CFU total) was inoculated into the nares of female 6.5-week-
old C57BL/6 mice (Charles River Laboratories, Boston, MA) anesthetized with
ketamine (65 mg/kg of body weight) and xylazine (6.5 mg/kg) by intraperitoneal
(i.p.) injection. At 40 h of infection, lungs were harvested and homogenized using
a Fisher Tissuemiser homogenizer. Dilutions of the lung homogenate were
plated on sBHI agar plates with or without 1 mM D-xylose and X-Gal (5-bromo-
4-chloro-3-indolyl -D-galactopyranoside; Sigma-Aldrich, St. Louis, MO) for
CFU enumeration. For statistical analysis of mixed infections, the ratio of each
experimental strain to NTlacZ was calculated, multiplied by 100, log10 trans-
formed, and analyzed using one-way analysis of variance (ANOVA) with Tukey’s
multiple-comparison test (Prism 5.03; GraphPad Software, La Jolla, CA). For
single-strain infections, numbers of CFU per lung were calculated and analyzed
by t test. All animal procedures were conducted in accordance with NIH guide-
lines and with prior approval by the University of Massachusetts Medical School
Institutional Animal Care and Use Committee.
EDTA sensitivity and growth curve analysis. Strains were inoculated from
standing overnight cultures at an OD600 of 0.01 into 25 ml of sBHI in a 50-ml
flask and incubated with shaking at 250 rpm and 35°C until mid-log phase.
These cultures were used to inoculate sBHI medium containing EDTA (at
the final concentrations specified) at an OD600 of 0.02, and 100 l was
dispensed into the wells of a 96-well microtiter plate (Corning) prefilled with
100 l sBHI broth containing EDTA (final concentrations specified in Re-
sults). When necessary, the medium was supplemented with MgCl2, CaCl2,
MnCl2, FeCl3, CoCl2, NiCl2, CuSO4, ZnSO4, or Na2MoO4 to a final concen-
tration of 30 or 60 M. As a control, strains were also grown in sBHI medium
without additions. For double mutant analysis, strains were grown in medium
containing various concentrations of EDTA (final concentration of 0.0025
mM, 0.005 mM, or 0.01 mM) or medium containing various concentrations of
ZnSO4 (final concentration of 0.001 mM, 0.003 mM, or 0.05 mM). Microtiter
plates were incubated at 35°C for 10 h in a Versamax microplate reader
(Molecular Devices, Sunnyvale, CA) set to read the absorbance at 600 nm
every 10 min. Effects of EDTA concentration and metal supplementation on
strains were assessed by relative growth yields and generation times (Prism
5.03; GraphPad Software, La Jolla, CA).
Purification of ZevA-His. To purify the ZevA-His fusion protein, 1-liter
cultures of strain ECZevAHis were inoculated from 10-ml overnight cultures
and grown in Luria-Bertani broth containing 100 g/ml ampicillin with shak-
ing at 200 rpm and 37°C. When cultures achieved an OD600 between 0.6 and
0.8, L-arabinose was added to a final concentration of 0.02%, and cultures
were incubated for an additional 3 h. After incubation, cells were pelleted by
centrifugation at 5,000  g for 10 min, resuspended in 25 mM Tris-HCl (pH
8.0) and 500 mM NaCl, and lysed using a French pressure cell. Lysates were
cleared by ultracentrifugation at 30,000  g, and protein was purified by
affinity chromatography using a Ni2-nitrilotriacetic acid (Ni-NTA) column
(Qiagen, Valencia, CA). Protein was eluted using buffer containing 150 mM
imidazole and concentrated by centrifugation in an Amicon Ultra 10-kDa
cutoff filter (Millipore, Billerica, MA). To remove the His tag, ZevA-His
fusion protein was incubated with purified 6His-tagged TEV protease (1:1
molar ratio) for 1 h at 22°C in buffer containing 50 mM HEPES-NaOH (pH
7.5), 200 mM NaCl, 3 mM reduced glutathione, and 0.3 mM oxidized gluta-
thione. After incubation, TEV-His was removed by affinity purification with
Ni-NTA resin (see Fig. S1 in the supplemental material). Protein concentra-
tion was determined using the Bradford reagent (Sigma-Aldrich, St. Louis,
MO). Purity was assessed by Coomassie brilliant blue staining of overloaded
SDS-PAGE gels and by immunostaining Western blots with rabbit anti-His
polyclonal primary antibody (GenScript, Piscataway, NJ) and goat anti-rabbit
IgG secondary antibody (horseradish peroxidase conjugate; GenScript,
Piscataway, NJ). Purified untagged ZevA was determined by densitometry to
be at least 99% pure of ZevA-His and 98% pure of TEV-His (see Fig. S1).
For Zn2 binding assays, reaction buffer was exchanged with 50 mM HEPES-
NaOH (pH 7.5), 200 mM NaCl, and 10% glycerol by centrifugation in an
Amicon Ultra 10-kDa cutoff filter (Millipore, Billerica, MA).
Zn2 binding stoichiometry determination. Stoichiometry assays were per-
formed as described previously (18). ZevA protein (0.8 M) was incubated for 1
min at room temperature in the presence or absence of 50 M ZnSO4. Buffer (50
mM HEPES-NaOH, pH 7.5, 200 mM NaCl, and 10% glycerol) containing 50 M
ZnSO4 was incubated in parallel as a control. After incubation, excess Zn2 was
removed by size exclusion with Sephadex G-25 columns. Eluted protein was acid
digested with concentrated nitric acid overnight at room temperature. Following
digestion, samples were treated with H2O2 to a final concentration of 1.5%. The
concentration of Zn2 in each sample was measured using atomic absorption
spectroscopy (AAS) (AAnalyst 300; PerkinElmer, Waltham, MA). Average
background Zn2 levels detected for control samples were 2% of levels de-
termined for ZevA-Zn2 samples.
Determination of ZevA affinity for Zn2. The binding affinity of ZevA for
Zn2 was determined using the Zn binding chromophore mag-fura-2 (Invitro-
gen, Carlsbad, CA) as previously described (18, 37, 67). Briefly, 10 M ZevA
protein and 20 M mag-fura-2 were mixed and titrated with 1 mM Zn2. Free
mag-fura-2 was determined by monitoring OD366, using an ε366 of 29,900 M1
cm1 (68). Free Zn2 concentrations were calculated using the equation KI 	
[I  Zn2]/[Ifree][Zn2], where I is the concentration of mag-fura-2, Ifree is free
mag-fura-2, and KI is the association constant of mag-fura-2 for Zn2 (KI 	 5 
107 M1) (37, 68). The Zn2-protein association constant (Ka) and the apparent
stoichiometry (n) of ZevA were calculated by fitting the data to the equation v 	
nKa[Metal]f/(1  Ka[Metal]f), where v is the ratio of moles of metal bound to
total protein, n is the number of binding sites, and [Metal]f is the free metal
concentration (25).
qRT-PCR. RNA was prepared from liquid cultures of Rd using an RNeasy
minikit and an on-column DNase I kit (Qiagen, Valencia, CA). The RNA
samples (5 g) were used as templates for cDNA synthesis with Random Primer
9 (New England BioLabs, Beverley, MA) and SuperScript II reverse transcrip-
tase (Invitrogen, Carlsbad, CA). Quantitative reverse transcription-PCR (qRT-
PCR) was performed with iQ SYBR green supermix (Bio-Rad Laboratories,
Hercules, CA), and fluorescence was measured over time using the DNA Engine
Opticon II system (MJ Research, Waltham, MA). For transcript analysis of zevA
and zevB, qRT-PCR was performed with primers 51249RT and 31249RT and
primers 51248RT and 31248RT, respectively. Primers RpoA5 and RpoA3 were
used to amplify the RNA polymerase alpha subunit gene, rpoA, as an internal
reference. The real-time cycler conditions used have been described previously
(71). The mock reverse transcription reactions, containing RNA and all reagents
except reverse transcriptase, confirmed that the results obtained were not due to
contaminating genomic DNAs (data not shown).
Reporter expression analysis. Strains were plated at a density of 2  105 CFU
per plate on sBHI agar with or without 100 mM ZnSO4 addition and incubated
at 35°C overnight in either an open air incubator or an anaerobic chamber. Cells
were swabbed from plates and diluted into Z buffer (42) to a concentration of
1  109 bacteria per ml (OD600 of 0.333). Alternatively, cells were cultured in
sBHI broth containing 0.5 mM EDTA with shaking at 250 rpm and 35°C until
mid-log phase before being diluted into Z buffer. The -galactosidase (-Gal)
assay was then performed as described previously (42). The optical density at 420
nm (OD420) was recorded using a Versamax microplate reader (Molecular De-
vices, Sunnyvale, CA) and converted to Miller units with the equation Miller
Units 	 (1,000  OD420)/(T  V  OD600), where T is the time in minutes and
V is the volume of the reaction mixture.
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RESULTS
Identification of secreted factors involved in H. influenzae
pathogenesis. An informatics-based approach was utilized to
compile a database of the exported proteins in H. influenzae
that are likely to require DsbA for oxidative folding. First,
web-based prediction servers SignalP (7) and LipoP (32) were
used to identify polypeptides with predicted cleavage sites for
signal peptidase I (soluble exported proteins) and signal pep-
tidase II (lipoproteins), respectively. Next, the list was refined
to include only mature proteins (excluding leader peptides)
with two or more cysteine residues, as these are expected to be
DsbA substrates (50). The -barrel outer membrane protein
predictor (BOMP) (9) and membrane topology prediction
servers TMHMM (63) and Phobius (33) were used to predict
the locations of cysteines in the loops of membrane proteins,
thereby excluding proteins with cysteines that are predicted to
be cytoplasmic and inaccessible to DsbA. The final database
includes secreted proteins involved in a variety of functional
processes, which are cataloged based on Clusters of Ortholo-
gous Groups (COG) in Table S2 in the supplemental material.
Next, to identify the putative substrates of DsbA that are
required for pathogenesis of H. influenzae, we cross-referenced
the list of genes in Table S2 in the supplemental material with
the set of genes previously implicated in survival of H. influ-
enzae Rd in the lung, as identified by the HITS technique (22).
In that study, transposon mutant libraries were acquired before
and after selection for survival in the mouse lung model, and
transposon/chromosomal junctions were amplified from
genomic DNA, captured, sequenced, and aligned with the H.
influenzae genome sequence. The results of the analysis were
reported as a survival index (s.i.), which denotes the number of
mutations detected in a given gene in the lung-selected output
library divided by mutations detected in the in vitro-grown
input library. Genes required during lung infection were iden-
tified on the basis of two parameters: having an s.i. of 0.3 or
lower and sustaining insertions in 
40% of the potential TA
dinucleotide insertion sites, specific to the himar1-derived
transposon used in the study (22). Comparison of our list of
potential DsbA substrates to the results of HITS revealed
three genes that fit these criteria: znuA (s.i., 0.101), encoding
the periplasmic component of a high-affinity zinc uptake trans-
porter (39, 53), nlpD (s.i., 0.000), encoding a lipoprotein sug-
gested to be involved in daughter cell separation (64, 65), and
HI1249 (s.i., 0.106), encoding a putative protein herein re-
ferred to as ZevA. The role of znuA in virulence has been
studied by several groups (3, 11, 14, 21, 36, 57, 75), and nlpD
has been implicated in the virulence of Yersinia pestis and
Yersinia enterocolitica (12, 64). However, zevA has not been
previously investigated and its role in virulence is unknown.
Additionally, the putative gene 2 bp downstream of the 3 end
of the zevA coding sequence, HI1248, herein referred to as
zevB, was also found to be required for lung survival (s.i.,
0.103).
The results of HITS were verified using genetic footprinting
on our mutant libraries. In this technique, transposon inser-
tions in a given region are physically mapped using PCR with
a chromosome-specific primer paired with a transposon-spe-
cific primer (1, 61). The size of the amplified product corre-
sponds to the distance between the chromosome-specific
primer and the transposon insertion within that gene. In agree-
ment with HITS, footprints of the library recovered from lung
infection reveal a reduction in transposon insertions within the
zevAB locus compared with footprints of the input library (Fig.
1). These data indicate that zevA and zevB are essential for
lung colonization by H. influenzae Rd.
zevAB is required for efficient NTHI infection of the mouse
lung. Mutants of zevA and zevB were generated in an NTHI
clinical isolate, NT127 (28), to evaluate the roles of these genes
during in vitro growth and lung infection. Mutants were con-
structed by replacement of coding regions with a drug resis-
tance marker to generate nonpolar deletions, and complemen-
tation was conducted using an exchange vector for delivery and
expression at the xylose locus (70). The complete strain set
consisted of the parent strain carrying the empty vector (NTV),
the zevA mutant carrying the empty vector (NTzevAV), the
zevB mutant carrying the empty vector (NTzevBV), and com-
plemented zevA and zevB mutants (NTzevAX and NTzevBX,
respectively) (Table 1). When grown aerobically in sBHI me-
dium, all strains had equivalent growth yields and generation
times (NTV, 45.4  1.7 min; NTzevAV, 44.1  1.3 min;
NTzevBV, 41.6  0.6 min; NTzevAC, 43.0  0.5 min; and
NTzevBC, 44.2  1.9 min). Ratios of CFU to optical densities
at 600 nm were indistinguishable between these strains.
Next, these strains were evaluated for their ability to infect
the lungs of C57BL/6 mice. This experiment was performed
using mixed infections in which a competition was performed
between each strain and strain NTlacZ, which expresses E. coli
lacZ at the xyl locus. At 40 h after inoculation, average com-
petitive indices (c.i.) were 3-fold lower for the zevA mutant
(NTzevAV; c.i., 0.364) and22-fold lower for the zevB mutant
(NTzevBV; c.i., 0.064) compared to that for the parent strain
(NTV; c.i., 1.22) (Fig. 2). Complementation restored the ability
FIG. 1. Analysis of transposon insertions within the zevAB locus. In
vitro-selected (Input) and in vivo-selected (Output) libraries were com-
pared using HITS and genetic footprinting data. Bars represent the
number of sequencing reads at each individual insertion site within the
zevAB region. The positions of molecular weight standards are dis-
played to the right and apply to both HITS plots and footprints. The
positions of the zevA and zevB genes are indicated. Genetic footprint-
ing was performed by PCR with transposon-specific primer marout
and chromosome-specific primer 31248rev (represented by the arrow),
which binds 661 bp downstream of zevB.
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of the mutants to survive in the lung, verifying that defects are
specific to mutation of zevA and zevB. The complemented
strains, NTzevAX and NTzevBX, exhibited competitive indi-
ces that were slightly higher than that of the parent strain,
likely due to increased expression of the complementing genes
due to the presence of both the zevA and xylA promoters in the
constructs. To examine the possibility that mixed infection
influences relative survival of the mutants, the zevA mutant was
evaluated in the lung model in single-strain infections. Consis-
tent with results obtained with mixed infections, average CFU
recovery at 40 h postinfection was significantly reduced (P 	
0.027) 3.5-fold for the zevA mutant compared to that for the
parent strain (data not shown). In agreement with HITS anal-
ysis of Rd, these data indicate that the zevAB genes are re-
quired for colonization and survival of pathogenic NTHI in the
mouse lung but are not required for normal growth in rich
medium.
Bioinformatic analysis of zevA and zevB. BLAST (2) reveals
that zevA and zevB of H. influenzae are conserved in other
bacterial species within the Pasteurellaceae and Enterobacteri-
aceae, including several human pathogens such as Klebsiella
pneumoniae, Yersinia pestis, Proteus mirabilis, and Salmonella
enterica serovar Typhimurium (Table 2). In the Conserved
Domains Database (CDD) (40), ZevA and ZevB are anno-
tated by structural domain classification as the periplasmic
substrate-binding protein (PBP) and the permease subunit of
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Genotype, description, and/or relevant features Reference or source
Strains
NT127 Nontypeable H. influenzae clinical isolate 28
NTV NT127 xylA4-804::tetAR; tetAR sequence from pXT10 replaces xylA 28
NTzevAV NT127 zevA::aacCI, xylA4-804::tetAR; zevA deletion mutant with tetAR Tc
r cassette replacing xylA This study
NTzevAX NT127 zevA::aacCI; xylA4-804::zevA; zevA deletion mutant complemented with zevA expressed
via the zevA promoter in place of xylA
This study
NTzevBV NT127 zevB::aacCI; xylA4-804::tetAR; zevA mutant replacing xylA This study
NTzevBX NT127 zevB::aacCI; xylA4-804::zevAB; zevB deletion mutant complemented with zevAB expressed
via the zevA promoter in place of xylA
This study
NTlacZ NT127 xylA4-804::lacZ; lacZ coding sequence expressed via the xylA promoter replacing xylA This study
NTznuA NT127 znuA::aphI, xylA4-804::tetAR; znuA deletion mutant with tetAR Tc
r cassette replacing xylA This study
NTzevAznuA NTzevAV znuA::aphI; zevA and znuA double mutants This study
NTzevBznuA NTzevBV znuA::aphI; zevB and znuA double mutants This study
NTZnuB NT127 znuBC::aphI, xylA4-804::tetAR; znuBC deletion mutant with tetAR Tc
r cassette
replacing xylA
This study
NTzevAznuBC NTzevAV znuBC::aphI; zevA and znuBC double mutants This study
NTzevBznuBC NTzevBV znuBC::aphI; zevB and znuBC double mutants This study
Rd AW Wild type; H. influenzae capsule-deficient type d 70
R5 Rd zevAB::lacZ; zevAB deletion mutant with lacZ expressed via the zevA promoter (zevA
reporter strain)
This study
R5X R5 xylA4-804::zevAB; strain R5 complemented with zevAB expressed via the zevA promoter
replacing xylA
This study
R5fnr R5 fnr::nptII; fnr mutant of strain R5 with Kmr transposon insertion in fnr This study
R5fnrX R5 fnr xylA4-804::fnr; fnr mutant of strain R5 complemented with fnr expressed via the fnr
promoter in place of xylA
This study
RdlacZ Rd xylA4-804::lacZ; lacZ coding sequence expressed via the trc promoter replacing xylA 71
Plasmids
pXT10 Delivery vector for chromosomal expression at the xylose locus of H. influenzae containing xylF,
xylB, xylA4-804, and the tetAR tetracycline resistance cassette
70
P1249J pXT10 carrying zevA from NT127 expressed from the zevA promoter This study
p1248J1 pXT10 carrying zevAB from NT127 expressed from the zevA promoter This study
pX1248R pXT10 carrying zevAB from Rd expressed from the zevA promoter This study
pXELacZ2 pXT10 carrying lacZ expressed from the xylA promoter This study
FIG. 2. Effect of zevA and zevB mutations on survival of NTHI in
the mouse lung infection model. Mice were coinfected with refer-
ence strain NTlacZ and the parent strain carrying the empty vector
(NTV), the zevA mutant (NTzevAV), the complemented zevA mu-
tant (NTzevAX), the zevB mutant (NTzevBV), or the comple-
mented zevB mutant (NTzevBX). Bacteria were recovered from
lung homogenates after 40 h. Competitive indices (c.i.) are calcu-
lated as the ratio of recovered CFU of the LacZ experimental
strain to recovered CFU of the LacZ reference strain. The sym-
bols indicate data for individual animals, and the dashed lines
indicate averages. The lower limit of detection was a c.i. of 0.001.
Relevant statistical comparisons are indicated by brackets, and P
values were determined using ANOVA with Tukey’s multiple-com-
parison test. NTV, n 	 8; NTzevAV, n 	 7; NTzevAX, n 	 8;
NTzevBV, n 	 7; NTzevBX, n 	 6.
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an ATP-binding cassette (ABC) transporter, respectively.
ZevB is also annotated as a member of the NiCoT superfamily
of potential nickel/cobalt importers and exporters (2). This
superfamily is comprised of a diverse group of eight transmem-
brane segmented secondary transporters with a characteristic
HX4DH sequence in their second transmembrane span (17).
ZevB does not show these characteristics. Moreover, modeling
of ZevB using the consensus prediction of membrane protein
topology server (TOPCONS) (8) indicates that it contains only
the typical six transmembrane spans present in each of the two
transmembrane subunits observed in ABC ATPases (13). This
evidence suggests that ZevA and ZevB are partnering compo-
nents of an ABC ATPase transport system probably involved
in substrate influx.
ZevA and ZevB are important for growth of H. influenzae
during zinc limitation. Metal-restricted growth conditions can
be generated by titration of the medium with increasing con-
centrations of EDTA (3, 11, 54). To determine whether zevAB
is involved in metal acquisition in H. influenzae, strains were
grown in medium containing 0.25, 0.5, or 0.75 mM EDTA.
Mutants of zevA and zevB were able to acquire essential nu-
trients for optimal growth in rich medium, as evidenced by the
lack of apparent growth defects in vitro (Fig. 3A). However,
medium containing 0.5 mM EDTA inhibited growth of the
zevA and zevB mutants, in which growth yields at 10 h were
reduced by 81% and 87%, respectively, compared to that of the
parent or complemented strains, which grew normally (Fig.
3B). Supplementation with 0.25 mM EDTA had no effect on
the growth of any strains, whereas 0.75 mM EDTA signifi-
cantly reduced growth of the parent and complemented strains
in addition to that of the mutants (data not shown).
In preliminary studies, specific metals were added to me-
dium chelated with EDTA in an attempt to promote growth of
the mutants. The addition of MgCl2, CaCl2, MnCl2, FeCl3,
CoCl2, NiCl2, CuSO4, or Na2MoO4 at a concentration of either
30 or 60 M had no significant effect on the growth of the zevB
mutant in the presence of 0.5 mM EDTA (data not shown). In
contrast, addition of 30 M ZnSO4 partially restored the
growth of the zevB mutant and addition of 60 M ZnSO4
completely restored growth to the level of the parent strain.
Figure 3C shows that in the presence of 0.5 mM EDTA, ad-
dition of 60 M zinc restores both the zevA and zevB mutants
to levels of the parent and complemented strains. These data
suggest that zevAB is important for the growth of H. influenzae
under conditions where free zinc is limiting.
ZevA protein binds zinc with high affinity. Metal binding
assays were performed to determine whether ZevA binds Zn2
and therefore can participate in metal uptake. Recombinant
ZevA was cloned, expressed in Escherichia coli, and affinity
purified, and the metal binding tag was removed. After incu-
bation in the presence of Zn2, the amount of metal bound to
ZevA was determined by atomic absorption spectroscopy
(AAS). The results indicate that ZevA binds 1.9  0.3 Zn2
ions per mol of ZevA. The affinity of ZevA for Zn2 was
determined in metal competition assays including ZevA and
mag-fura-2. The fluorescent metal chelator mag-fura-2 binds
TABLE 2. BLAST results of H. influenzae Rd ZevA and ZevB homologs in other pathogensa
Organism
ZevA (HI1249) ZevB (HI1248)
Locus ID Identity(%)
Length
(aa) Expect value Locus ID
Identity
(%)
Length
(aa) Expect value
H. influenzae NT127 HIAG_01363 97 206 2e117 HIAG_01364 96 322 5e165
Klebsiella pneumoniae 342 Kpk_1251 42 199 7e42 Kpk_1252 36 326 2e40
Yersinia pestis KIM 10 y1329 43 224 3e41 y1330 38 340 7e52
Proteus mirabilis HI4320 PMI1519 37 221 2e32 PMI1518 38 333 8e47
Salmonella enterica serovar Typhimurium LT2 STM2552 37 212 1e33 STM2551 38 328 1e50
a ID, identification. HI1249, 206 amino acids (aa); HI1248, 322 (aa).
FIG. 3. Growth phenotypes of zevA and zevB mutants in liquid
medium. The parent strain (NTV), zevA mutant (NTzevAV), comple-
mented zevA mutant (NTzevAX), zevB mutant (NTzevBV), and com-
plemented zevB mutant (NTzevBX) were grown in sBHI (A), sBHI
containing 0.5 mM EDTA (B), or sBHI containing 0.5 mM EDTA
supplemented with 60 M ZnSO4 (C). Symbols represent average
absorbance (Abs) readings for three cultures. Error bars indicate stan-
dard deviations (SD).
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Zn2 with a Ka of 5  10
7 M1, and this is associated with a
shift from 366 nm to 325 nm in the chelator’s spectrum max-
imum. Thus, the decrease in OD366 was used to calculate the
concentrations of the various species in the assay. Figure 4
shows the results of these assays. Cooperativity in binding to
the two Zn2 binding sites was not observed. Fitting the data
to a Langmuir equation yielded an association constant of
ZevA for Zn2 of 1.9  107  0.3  107 M1. This affinity is
similar to those observed for other known Zn2 binding pro-
teins (15, 24, 37).
Relative contributions of zevAB and znuABC in zinc utiliza-
tion. Aside from the ZevAB system presented here, only one
other system has been implicated in zinc utilization of H. in-
fluenzae, the high-affinity zinc transporter ZnuABC. An H.
influenzae znuA (originally called pzp1) mutant was shown to
exhibit growth defects in normal medium that could be rescued
by addition of zinc, and recombinant ZnuA bound up to 5
molecules of zinc per protein (39). The znuBC genes have also
been demonstrated to participate in zinc utilization in other
organisms (11, 53), including Pasteurella multocida (21), a
close relative of H. influenzae, and are thought to encode the
ATPase (znuC) and membrane permease (znuB) components
of the transporter (52, 53). To evaluate the conditions under
which ZevAB and ZnuABC are needed, their relative contri-
butions to the growth of H. influenzae were examined through
single and double mutant analyses. First, a znuA mutant was
generated by replacement of its coding region with an antibi-
otic resistance marker, and its growth was compared to that of
the zevA and zevB mutants. The znuA mutant (NTznuA) ex-
hibited an 16% increase in generation time in sBHI broth
relative to the parent strain (NTV), zevA mutant (NTzevAV),
and zevB mutant (NTzevBV) (Fig. 5A). Addition of 60 M
zinc restored growth of the znuA mutant in rich medium to
wild-type levels (data not shown), similar to results previously
reported for znuA mutants of other H. influenzae strains (39).
When grown in 0.1 mM EDTA, the znuA mutant exhibited
both a 21-fold reduction in growth yield at 10 h and a 2.3-fold
increase in generation time compared with growth of this
strain in sBHI medium, whereas the parent strain, zevA mu-
tant, and zevB mutant grew normally under this condition (Fig.
5B). In the presence of 0.5 mM EDTA, the growth yield of the
znuA mutant was also reduced 21-fold compared to that the
parent strain (Fig. 5C). Additionally, growth yields of the zevA
and zevB mutants were reduced by 67% compared with that of
the parent strain, similar to data reported for these strains in
Fig. 3B. A znuBC deletion, which was also constructed by gene
replacement, exhibited defects similar to those of the znuA
mutant during growth in rich medium or medium containing
0.5 mM EDTA (data not shown), providing evidence that
ZnuBC functions together with ZnuA in NTHI as components
of the zinc transport system described previously for other
organisms (11, 21, 53).
Next, to examine the role of zevAB in zinc uptake in the
absence of the znuABC pathway, double mutants were gener-
ated by deletion of znuA or znuBC in either the zevA or
zevB mutant background. The growth phenotypes of the dou-
ble mutants were equal in severity to that of the znuA or znuBC
mutant in sBHI medium, sBHI with various concentrations of
EDTA (0.0025 mM, 0.005 mM, or 0.01 mM), or sBHI supple-
mented with various concentrations of zinc (0.001 mM, 0.003
mM, or 0.05 mM). The lack of an additive effect of zevA or
FIG. 4. Zn2 binding to purified recombinant ZevA. The associa-
tion constant (Ka) and the number of metal binding sites (n) of ZevA
were calculated by fitting the data to the equation v 	 nKa[Metal]f/
(1  Ka[Metal]f), where v is the ratio of moles of metal bound to total
protein and n is the number of binding sites. Symbols represent the
averages of three independent measurements, and error bars indicate
standard errors.
FIG. 5. Growth phenotypes of zevA, zevB, and znuA mutants in
liquid medium. The parent strain (NTV), zevA mutant (NTzevAV),
zevB mutant (NTzevBV), and znuA mutant (NTznuA) were grown in
sBHI (A), sBHI containing 0.1 mM EDTA (B), or sBHI containing 0.5
mM EDTA (C). Symbols represent average absorbance (Abs) readings
for three cultures. Error bars indicate SD.
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zevB mutation in combination with znuA or znuBC mutation
indicates that ZevAB does not substitute for ZnuABC for zinc
uptake at these zinc concentrations. Taken together, these data
suggest that ZevAB functions in a specialized pathway needed
only when the concentration of free zinc is low in contrast to
that of ZnuABC, which is essential for growth over a wide
range of free zinc concentrations.
FNR participates in regulation of the ZevAB operon. In
many species that have been examined, transcriptional regula-
tion of bacterial genes involved in zinc uptake is mediated by
the zinc-responsive metalloregulatory protein Zur (27). When
zinc is abundant in the cell, dimerized Zur binds to a specific
palindromic sequence in promoters to repress transcription of
zinc uptake genes, such as znuABC of E. coli (53) and zinT of
S. Typhimurium (54). However, previous studies, as well as our
own BLAST searches, indicate that the Pasteurellaceae do not
contain a zur homolog (21). In these organisms, zinc uptake is
likely regulated by other mechanisms. For example, in Pasteu-
rella multocida, znuABC is regulated by the iron response reg-
ulator Fur (21).
To investigate the potential regulation of zevAB, the 330-bp
region directly upstream of the zevA translational start site
from the start codon of HI1250 (negative strand relative to the
zevA coding sequence) to the start codon of zevA (positive
strand) was analyzed for potential transcriptional regulator
binding sites. A palindromic sequence between 235 and 248 bp
upstream of the HI1250 start codon that was conserved in both
Rd and NT127 strains was identified (Fig. 6A). This sequence
matches the known consensus binding site for the oxygen-
responsive transcriptional regulator FNR (16, 41). FNR di-
rectly senses a range of low-oxygen conditions and binds to
DNA to either repress genes required for aerobic growth or
activate those needed for growth under low-oxygen conditions
(28, 35).
To determine the expression profiles of zevA and zevB, we
first examined the transcription of these genes in the Rd strain.
Cultures were grown in liquid medium, and transcript levels
were determined by quantitative PCR, revealing that zevA and
zevB are expressed similarly to the reference gene rpoA, which
encodes RNA polymerase. Together with their genomic orga-
nization, these data suggest that zevA and zevB may be ex-
pressed via the same promoter.
Next, to determine whether the zevAB genes are regulated in
response to oxygen, reporter strain R5 was constructed as a
zevA promoter-lacZ fusion with deletion of zevAB in the Rd
background (Fig. 6A). A complemented reporter strain, R5X,
was also generated in which the zevAB genes were expressed
via their native promoter at the xyl locus in trans to the zevA
promoter-lacZ fusion. When grown aerobically (sBHI agar
plate), -Gal activities were similar between the reporter
strain, R5, and the complemented reporter strain, R5X (Fig.
6B). When bacteria were grown anaerobically, -Gal activities
were reduced for both strains by50% compared with aerobic
levels. A strain carrying an fnr disruption mutation in the R5
background, R5fnr, exhibited 80% greater -Gal activity
than the parent reporter strain or complemented reporter
strain under anaerobic conditions, effectively restoring activity
to levels observed for the parent strain under aerobic condi-
tions. The fnr mutant also exhibited an 25% increase in
-Gal activity compared with the parent strain under aerobic
conditions, likely due to oxygen availability decreasing as cul-
ture density increases on the plate. Complementation restored
levels of fusion expression in the fnr mutant to those of the wild
type. Additionally, RdlacZ, a strain expressing lacZ via a con-
stitutive promoter, produced equivalent -Gal levels in both
the aerobic and anaerobic environments, suggesting that -Gal
activity itself is not affected by the growth condition (Fig. 6B).
To examine whether free zinc concentrations affect zevA
reporter expression, the complemented reporter strain, R5X,
was grown in liquid medium in the presence or absence of 0.5
mM EDTA under aerobic conditions. In this assay, -Gal
levels of R5X were indistinguishable between the two condi-
tions (data not shown). When R5X was grown under either
aerobic or anaerobic conditions in medium supplemented with
100 mM zinc (a concentration nontoxic to H. influenzae), -Gal
levels were similar to those observed for this strain in normal
sBHI medium (data not shown). Taken together, these data
indicate that expression from the zevA promoter is unaffected
by the presence or absence of zevAB or changes in free zinc
concentrations and is repressed by FNR under oxygen-limiting
FIG. 6. FNR-mediated regulation of the zevA promoter. (A) Sche-
matic of zevA promoter-lacZ fusion construct inserted into the Rd
genome at the zevAB locus. The 330-bp intergenic region from the start
codon of HI1250 to the start codon of lacZ is displayed above. A
potential FNR binding site is indicated by a box, and bold letters
indicate the palindromic sequence. The predicted 10 and 35 pro-
moter elements are underlined. (B) -Galactosidase activity. The par-
ent strain (Rd), reporter strain (R5), complemented reporter strain
(R5X), reporter strain carrying an fnr mutation (R5fnr), comple-
mented fnr mutant (R5fnrX), and positive-control strain (RdlacZ)
were plated at a density of 5  108 CFU, grown in aerobic and
anaerobic environments, and assayed for the production of -galacto-
sidase. Values are displayed in Miller units. Relevant statistical
comparisons are indicated by brackets, and P values were deter-
mined using ANOVA with Tukey’s multiple-comparison test. Bars
represent average measurements for three technical replicates. Er-
ror bars indicate SD.
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conditions. Furthermore, a higher level of zevA promoter ac-
tivity in the aerobic environment is consistent with the require-
ment of zevAB for lung infection, in which H. influenzae is
likely to encounter high oxygen concentrations.
DISCUSSION
Secreted bacterial proteins mediate critical aspects of patho-
genesis and often require disulfide bond formation in the
periplasm to stabilize their mature structures. Due to their
extracytoplasmic location and accessibility, identification of
these factors may aid in the design of novel therapeutics or
vaccines for combating NTHI infections. Here, we generated a
list of potential substrates of the periplasmic disulfide oxido-
reductase protein DsbA (see Table S2 in the supplemental
material) and integrated our findings with the results of a
previous study in which HITS technology was used to identify
genes required for lung infection (22). Using this strategy, we
identified three genes that were potentially important for lung
infection, including two, znuA and nlpD, that had previously
been implicated in the virulence of several organisms (3, 11, 12,
14, 21, 36, 57, 64, 75), and a third gene, zevA, whose function
had not been determined. Therefore, zevA and its neighboring
gene, zevB, were investigated for their roles in the pathogenesis
of a clinical NTHI isolate. NTHI mutants of zevA and zevB
were not defective for growth in vitro on rich medium com-
pared with the parent or complemented strain but exhibited
significant survival defects in a mouse lung infection model
(Fig. 2). These data confirmed that zevA and zevB are indis-
pensable for the virulence of H. influenzae strains in the murine
lung. Interestingly, several potential DsbA-dependent proteins
that were not required in the lung model as determined by
HITS are important for H. influenzae pathogenesis in other
sites of infection. For example, the hemopexin utilization
protein HxuA has been shown to be required for wild-type
bacteremic levels in an infant rat model of H. influenzae type
B infection (45), and the outer membrane protein P5
(OmpA) is required for virulence of NTHI in a chinchilla
model of otitis media (62). This suggests that examination of
the requirement for DsbA substrates in other H. influenzae
infection models is likely to reveal additional mechanisms
involved in pathogenesis.
Informatics-based analysis of ZevAB suggested potential
roles in metal transport, and this possibility was explored. Mu-
tants of zevA and zevB were highly defective for growth in the
presence of 0.5 mM EDTA (Fig. 3B), suggesting that these
genes are important during metal-restricted growth. Supple-
mentation with 60 M zinc, but not other metals, was able to
rescue the growth of the zevA and zevB mutants in the presence
of 0.5 mM EDTA to levels of the parent and complemented
strains (Fig. 3C). The concentration of zinc in sBHI medium
was determined to be 40 M using AAS. Therefore, upon
chelation with EDTA, addition of 60 M likely restores free
zinc concentrations to the normal range found in sBHI media.
Together, these data indicate that zevAB is a novel zinc utili-
zation pathway important for growth of H. influenzae when free
zinc concentrations are limiting. Consistent with this observa-
tion, we also demonstrated that ZevA protein binds to two zinc
ions with high affinity (Fig. 4), similar to periplasmic binding
proteins of other high-affinity zinc transporters (15, 24).
H. influenzae encodes at least two zinc utilization systems,
the ZnuABC system and the ZevAB system described here.
Mutants of individual genes in both pathways were compared
for growth levels in rich or metal-restricted medium, and
growth defects of the znuA mutant were consistently more
severe than defects exhibited by the parent strain or zevA or
zevB mutant in rich medium or medium containing EDTA
(Fig. 5A, B, and C). These data are consistent with the role of
ZnuABC as a primary zinc transport system of H. influenzae,
required over a wide range of conditions, whereas contribu-
tions from ZevAB are important for supporting growth only
when zinc concentrations are limiting. Because double mutant
analysis revealed that strains lacking both Znu and Zev path-
ways are not completely inhibited for growth in rich medium,
it is likely that an additional pathway is involved in zinc acqui-
sition of this organism. One possibility is the PitA-dependent
inorganic phosphate utilization pathway, which was proposed
to be a low-affinity zinc transporter of E. coli (6). Whole-
genome mutant fitness analysis via HITS suggested that PitA is
required for optimal growth in vitro as well as for lung infection
(22). Together, these observations suggest that H. influenzae
contains several zinc utilization pathways whose functions are
specialized to maintain zinc homeostasis in diverse environ-
ments.
Consistent with our observation that these proteins partici-
pate in zinc utilization, bioinformatic analysis of ZevA and
ZevB suggested that they constitute PBP and membrane per-
mease components of an ABC-type transporter, respectively.
However, the zevAB locus does not encode a protein contain-
ing the Walker A and B nucleotide binding sequences known
to be required by ABC transporters for activity (13). HITS
analysis revealed seven genes required for lung infection that
are predicted to encode ABC-type ATPases (22). Possibly,
ZevAB utilizes one of these ATPases for function; however,
further investigation will be needed to address this question.
In many bacterial species, genes important for zinc acquisi-
tion and homeostasis are repressed in response to elevated
intracellular zinc levels by the transcriptional regulator Zur
(27, 54). Because H. influenzae does not contain a homolog of
this regulator and expression of zevAB was not influenced by
exogenous zinc levels, we sought to determine whether another
regulator was involved. Expression analysis using zevA pro-
moter-lacZ fusion reporter strains revealed that zevAB is re-
pressed under low-oxygen conditions by the oxygen-responsive
transcriptional regulator FNR (Fig. 6B). Of note, FNR has
been shown to positively regulate transcription of metal trans-
porters, such as nikABCDE nickel transport genes and feoABC
iron uptake genes of E. coli (34, 73) and feoABC, sitABCD, and
fhuA iron uptake genes of Shigella flexneri (10, 74). To our
knowledge, FNR-mediated regulation of genes involved in zinc
acquisition or homeostasis has not previously been demon-
strated.
A potential explanation for the repression of zevAB by FNR
is that maximum expression of zevAB may be detrimental to
the survival of H. influenzae in the anaerobic environment due
to excessive zinc uptake or that zevAB may be dispensable
during anaerobic growth and repressed to conserve resources.
However, an fnr mutant and a wild-type strain were equally
sensitive to a range of toxic zinc concentrations during anaer-
obic growth, and defects in the growth of a zevB mutant in
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zinc-limiting medium were not significantly different under
aerobic and anaerobic conditions (C. V. Rosadini, unpublished
results). Ultimately, regulation of zevAB by FNR may serve as
an important strategy for increasing this system’s expression
exclusively in sites of infection where the bacterium encounters
zinc limitation, as is likely to occur at airway mucosal surfaces,
and is consistent with other reports indicating that oxygen is an
important signal for modulation of virulence factor expression
in H. influenzae (69, 71, 72).
Bacteria are thought to contain high-affinity zinc transport-
ers as a strategy to overcome zinc limitation during infection in
which the acute phase response has been shown to result in
reduced plasma zinc concentrations (20, 38) with upregulation
and release of the zinc binding complex calprotectin in the
blood and lungs (29, 31, 55). In accord with this hypothesis, we
demonstrated here that H. influenzae requires a specialized
high-affinity zinc utilization pathway for virulence. The finding
that zevAB is needed exclusively during growth under low-zinc
conditions and is required for lung infection suggests that bac-
teria growing in the lung experience zinc limitation that may
represent an immune defense for controlling pulmonary infec-
tion.
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